The brain’s immune cells are hyperactive in people who are at risk of developing schizophrenia, as well as during the earliest stages of the disease, according to a new study by researchers at the MRC Clinical Sciences Centre in London. The findings, published today in the American Journal of Psychiatry, suggest that inflammatory processes play an important role in the development of the disease, and raise the possibility that it could be treated with drugs that block or reduce this cellular response.
More on the same topic:
Immune clue to preventing schizophrenia
Heres a video for the same research